Product Information
DROXIDOPA 100 MG CAPSULE is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.7854 per EA under NDC 70436014006. Its NADAC has been published 100 times since Jun 21, 2023.
Strength
100 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436014006
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/23/2025
Active Ingredients
DROXIDOPAApproval Type
Generic (ANDA)
FDA Application
ANDA215265On Market Since
11/10/2021
Pharmacological Classes
Price Statistics
The NADAC for DROXIDOPA 100 MG CAPSULE has been published 100 times since Jun 21, 2023, and over the history we have for it it has declined 21.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7854 per EA |
|---|---|
| All-time high | $1.0016 (Mar 13, 2024) |
| All-time low | $0.5163 (Mar 20, 2024) |
| Median price | $0.8634 |
| Average price | $0.8614 |
| Largest weekly change | +58.6% (Apr 17, 2024) |
| Weeks tracked | 100 |
| Tracking since | Jun 21, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 44% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DROXIDOPA 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DROXIDOPA 100 MG CAPSULE, manufactured by Slate Run Pharmaceuticals LLC, is $0.7854 per EA (NDC 70436014006), effective May 14, 2025.
How has the price of DROXIDOPA 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DROXIDOPA 100 MG CAPSULE has declined 21.6%. It has been tracked across 100 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for DROXIDOPA 100 MG CAPSULE?
Since Jun 21, 2023, the NADAC for DROXIDOPA 100 MG CAPSULE has ranged from a low of $0.5163 (Mar 20, 2024) to a high of $1.0016 (Mar 13, 2024), with a median of $0.8634 per EA.
Are there cheaper alternatives to DROXIDOPA 100 MG CAPSULE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DROXIDOPA 100 MG CAPSULE, is $0.4419 per EA — about 44% below DROXIDOPA 100 MG CAPSULE.
Who manufactures DROXIDOPA 100 MG CAPSULE?
DROXIDOPA 100 MG CAPSULE (NDC 70436014006) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification